Issue 3/2011
Content (6 Articles)
Effect of Inhibition of Cytochrome P450 Enzymes 2D6 and 3A4 on the Pharmacokinetics of Intravenous Oxycodone
Juha Grönlund, Teijo I. Saari, Nora M. Hagelberg, Pertti J. Neuvonen, Kari Laine, Klaus T. Olkkola
Pharmacokinetics of Venlafaxine Extended Release 75 mg and Desvenlafaxine 50 mg in Healthy CYP2D6 Extensive and Poor Metabolizers
Alice I. Nichols, Kristen Focht, Qin Jiang, Sheldon H. Preskorn, Cecelia P. Kane
Effects of Nilotinib on Single-Dose Warfarin Pharmacokinetics and Pharmacodynamics
Ophelia Q.P. Yin, Neil Gallagher, Deirdre Fischer, Lily Zhao, Wei Zhou, Elisabeth Leroy, Georg Golor, Horst Schran
Effects of Structured Follow-Up and of More Effective Acid Inhibitory Treatment in the Management of GORD Patients in a Swedish Primary-Care Setting
Rickard Ekesbo, Svante Sjöstedt, Heléne Sörngård
Importance of C-Reactive Protein Level in Predicting Non-Response to Additional Intravenous Immunoglobulin Treatment in Children with Kawasaki Disease
Satoru Iwashima, Mituaki Kimura, Takamichi Ishikawa, Takehiko Ohzeki
Effects of Manidipine and its Combination with an ACE Inhibitor on Insulin Sensitivity and Metabolic, Inflammatory and Prothrombotic Markers in Hypertensive Patients with Metabolic Syndrome
Francisco J. Martinez-Martin, Alicia Macias-Batista, Cristina Comi-Diaz, Herminia Rodriguez-Rosas, Paula Soriano-Perera, Pablo Pedrianes-Martin